In the United States, once approximately 200 million COVID-19 vaccine doses have been administered, the COVID-19 pandemic will effectively be over in the sense that community transmission will be greatly reduced and the virus will have substantial difficulty spreading through the population.
“If we can get 200 million shots in arms…we can be done with the pandemic based on how many the efficacy of transmission rate reduction, combined with the fact that a certain number of people have already developed immunity to this thing, we get to the point that there should be kind of a, you know, think about a network and you start turning nodes off the network. Suddenly it becomes really hard to see transmission happen across the network.”
View on YouTube
Explanation
The US surpassed 200 million vaccine doses administered, but the pandemic did not end at that point; subsequent Delta and Omicron waves caused significant further transmission and death.
Around 45 days after mid-March 2021 (i.e., by roughly late April 2021), the United States will reach a point with COVID-19 vaccination progress and inventory where the country is clearly beginning to exit the pandemic phase (“skating out of this thing”), with improving epidemiological conditions driven by high vaccine supply and uptake.
“I do feel pretty good when you look at kind of the inventory forecast and you look at how many shots are being given per day, that in 45 days or so, we're going to get to a point that we're starting to skate out of this thing”
View on YouTube
Explanation
The US did not clearly exit the pandemic phase by late April 2021; the Delta variant wave began surging later that year.
Due to rising prices of key battery inputs (lithium, nickel, cobalt), Tesla will raise the selling price of its cars by roughly 20–30% in the near term, and this increase will be largely unavoidable for the company.
“the cost of Tesla's are going to go up by 20 or 30%. And there's nothing that there's nothing that Tesla could do.”
View on YouTube
Explanation
Tesla did raise vehicle prices multiple times in 2021 due to rising input costs, though not uniformly by the specific predicted 20-30% figure.
If meaningful inflation takes hold in the U.S. economy, prices will rise broadly across commodity products, including food, agricultural products, and metals.
“you'll see this across all commodity products if inflation takes hold in a in a meaningful way, um, including, uh, you know, food products, ag products, you know, um, all commodities, you know, metals.”
View on YouTube
Explanation
Broad commodity inflation across food, agricultural products, and metals did materialize through 2021-2022.
The rise of non‑dilutive financing products like Pipe and Clearbanc will materially change how venture capital investing is conducted as an industry over the coming years.
“I just think it's, uh, it's it's going to change the, the way in which venture investing is done.”
View on YouTube
Explanation
Non-dilutive financing products had some real impact on the venture landscape, but did not fundamentally reshape the industry as predicted.
Over the coming years, the growth of non‑dilutive financing will significantly change venture deal pricing (pre‑ and post‑money valuations), increase the equity share that employees can hold, and reduce the signaling value of traditional brand‑name venture firms like Sequoia relative to individual investors/operators.
“these non-dilutive ways of growing a company will completely impact pricing. You know, Pre-money Post-money the amount of equity that employees can and should own in these businesses, you know, what is the value of brands like you know it like people will know who David Sacks is and who Harry Hirst is. People necessarily don't even care anymore. Like, you know, hey, if I'm calling from Sequoia, what does that mean anymore?”
View on YouTube
Explanation
Similar reasoning: modest impact on deal pricing and brand signaling, not a clean confirmation of the predicted magnitude.
In the evolving market environment, retail and other investors will increasingly build portfolios of early‑stage, high‑risk public equities whose performance distribution will resemble venture portfolios: a small number of 10x winners, many total losses, and some modest-return positions.
“I think you're going to see these, um, these scenarios where people will build public portfolios, public public company portfolios that will perform a lot like venture portfolios, right? You'll have 1 or 2 businesses that'll have a ten bagger and, you know, a chunk that will go to zero and a chunk that'll have some modest return on them.”
View on YouTube
Explanation
The 2021 meme-stock/retail-trading era showed some of this venture-like portfolio pattern, though less so in subsequent years.
As speculative, early‑stage public listings proliferate, many investors will concentrate too much capital in single "sure thing" stocks, leading to significant losses for non‑diversified investors; only diversified portfolios across many such names will have a reasonable chance of producing good returns.
“it's going to be this, this tremendous learning experience, because a lot of people will put all their money into one stock that they think is already been made. It's already it's already a done thing... And so depending on the price you're entering and how many of these things you buy, you could build a portfolio that could have a good return. But it's it's going to be a lot of speculative betting and a lot of losses. And if you don't diversify you're going to lose a lot of money.”
View on YouTube
Explanation
Many concentrated, non-diversified retail positions from the 2021 speculative-listing era did suffer significant losses in the 2022 downturn, confirming the prediction.